Results 161 to 170 of about 4,535 (170)

Paxlovid Prescribing Requires Pharmacy Workload Assessments

American Journal of Health-System Pharmacy, 2022
openaire   +2 more sources

Paxlovid for treatment of COVID-19.

The Medical letter on drugs and therapeutics, 2022
openaire   +1 more source

Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China

Expert Review of Anti-Infective Therapy
Daxiong Zeng, , Guanghe Fei
exaly  

Decision letter for "Paxlovid‐associated dysgeusia"

2022
openaire   +1 more source

Effects of nirmatrelvir/ritonavir (Paxlovid) on the nervous system: analysis on adverse events released by FDA

Expert Opinion on Drug Safety
Zhen Zou
exaly  

Pharmacokinetic Interactions of Paxlovid Involving CYP3A Enzymes and P-gp Transporter: An Overview of Clinical Data

Current Drug Metabolism
Naina Mohamed Pakkir Maideen, Krishnaveni Kandasamy   +1 more
exaly  

METHOD FOR PREPARING INTERMEDIATE OF PAXLOVID

2023
WANG PENG, HU YIFANG, TIAN XIANGYIN, LIU GUOJIE, QIAN GANG   +4 more
openaire   +1 more source

Paxlovid for nonhospitalized patients with COVID‐19

Academic Emergency Medicine
Fatima Johari, Rajesh Verma
openaire   +2 more sources

Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID®) with Concomitant Medications in Real-World Clinical Settings

Pathogens
Jiří Sliva
exaly  

Paxlovid doesn't work. Surprise?

First10EM blog
openaire   +1 more source